TuHURA Biosciences, Inc.
HURA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $76 | $4 | $0 | $1 |
| - Cash | $13 | $4 | $14 | $6 |
| + Debt | $0 | $2 | $0 | $1 |
| Enterprise Value | $64 | $3 | -$14 | -$4 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$17 | -$29 | -$10 | -$6 |
| % Margin | – | – | – | – |
| Net Income | -$22 | -$29 | -$9 | -$7 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.214 | -11.291 | -324.485 | -903.035 |
| % Growth | 89.3% | 96.5% | 64.1% | – |
| Operating Cash Flow | -$15 | -$12 | -$8 | -$7 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$15 | -$12 | -$8 | -$7 |